NL-OMON45089
Completed
Not Applicable
Early detection of cardiovascular risk factors after pregnancy complicated by hypertensive disorders or spontaneous preterm birth - HyPreCare
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- cardiovascular disease after hypertensive disorders in pregnancy or after spontaneous preterm birth
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 687
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women with a history of early preeclampsia (\<34 weeks gestation) who gave labour in a University Medical Center in the Netherlands between 1998\-2005 (preeclampsia cases)
- •Women with a history of spontaneous preterm birth (\<37 weeks gestation) who gave labour in a University Medical Center in the Netherlands between 2001\-2008 (SPTB cases)
- •Women with a history of uncomplicated pregnancy who gave labour after 37 weeks of gestation in a University Medical Center in the Netherlandsbetween 1998\-2008 and within 3 months delivery of the case (controls)
Exclusion Criteria
- •Multiple pregnancy, chronic hypertension, diabetes mellitus before pregnancy or gestational diabetes during the index pregnancy, cardiovascular disease before pregnancy, renal disease, coagulation disorders, history of pregnancy complicated by fetal anomalies.
- •For SPTB cases also: iatrogenic preterm birth, uterine anomaly, history of conisation of the cervix
- •For controls exclusion: no pregnancies complicated by vascular complications.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Early detection of cardiovascular dysfunction and health behaviours in the young with type 2 diabetesType 2 diabetesNutritional, Metabolic, EndocrineISRCTN60207691niversity Hospitals of Leicester NHS Trust (UK)40
Completed
Not Applicable
Do women with polycystic ovary syndrome have increased cardiovascular risk compared to normal controls and could this risk be reduced by liraglutide?ISRCTN48560305Hull and East Yorkshire Hospitals NHS Trust (UK)40
Active, not recruiting
Not Applicable
Are early and late cardiovascular risk markers in women with Polycystic Ovary Syndrome increased with concomitant Nonalcoholic Steatohepatitis and can this be modified with Exenatide? - CV risk in PCOS and NASHEUCTR2008-006928-55-GBHull and East Yorkshire NHS Trust
Active, not recruiting
Phase 1
Are early and late cardiovascular risk markers in women with Polycystic Ovary Syndrome increased with concomitant Nonalcoholic Steatohepatitis and can this be modified with Liraglutide?Polycystic Ovary Syndrome Non-alcoholic SteatohepatitisMedDRA version: 12.0 Level: LLT Classification code 10065161 Term: Polycystic ovarian syndromeMedDRA version: 12.0 Level: LLT Classification code 10053219 Term: Non-alcoholic steatohepatitisEUCTR2009-015927-94-GBHull and East Yorkshire NHS Trust
Not yet recruiting
Not Applicable
To study the early changes in function of the heart in breast cancer patients undergoing chemotherapy using ultrasound scan of the heartCTRI/2023/06/053695Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal